Fujirebio Europe

Technologiepark 6
9052 Zwijnaarde
BE
Fujirebio Europe
Foundation date
18/07/1985
Sector
#Biotechnology - TherapeuticsSubsector
Therapeutic areas
- #Diseases of the blood and blood-forming organs - immune disorders
- #Endocrine - nutritional and metabolic diseases
- #Infectious and parasitic diseases
- #Mental and behavioural disorders
- #Neoplasms / cancer / oncology
Fujirebio is a global leader in the field of high quality in vitro diagnostics (IVD) testing. It has more than 50 years’ accumulated experience in the conception, development, production and worldwide commercialization of robust IVD products.Fujirebio has a strong and long-lasting tradition of collaborating with experts in the worldwide clinical community in the development of high-quality routine and truly novel biomarkers that cover a variety of disease states.
Upcoming events
All events-
0310 '23
-
1810 '23
EMDS2023@VIB
Event by: VIB -
1212 '23
BioFIT 2023
Event by: Eurasanté
Latest news
More news-
Triple discovery unveils insights into type 2 diabetes
Thursday September 28th 2023
Read more
-
SwiftPharma and Medace sign strategic collaboration agreement for biomanufacturing and purification of promising medicinal proteins.
Wednesday September 27th 2023
Read more
-
Mithra Announces Presentation of Positive Data on Estetrol (E4) Native Estrogen
Wednesday September 27th 2023
Read more
Jobs
More jobs-
29/09/23
Brussels
PhD position in Single particle cryo-EM of membrane proteins @ VIB-Structural Biology Brussels
Permanent
VIB -
27/09/23
Flemish Brabant
(Junior) Finance & ordering officer in internationale omgeving
Permanent
VIB -